Stress Response & Cortisol — Stress response physiology and cortisol effects (overview)

Historical Context & the Discovery of Stress Physiology

The modern understanding of the stress response has its roots in early twentieth-century physiology, when researchers first recognized that organisms mount coordinated neuroendocrine reactions to perceived threats. Before the concept of stress was formalized, clinicians observed that patients with diverse illnesses shared common symptoms—weight loss, adrenal enlargement, and immune suppression—suggesting a unifying physiological mechanism. The journey from these clinical observations to our current molecular understanding of cortisol signaling spans nearly a century and involves contributions from endocrinology, immunology, neuroscience, and clinical medicine. Understanding this history is essential for healthcare professionals because the stress response underlies the pathophysiology of conditions ranging from Cushing syndrome to major depressive disorder and metabolic syndrome.

The central question that these discoveries collectively address is deceptively simple: how does the body translate a psychological or physical threat into a coordinated biochemical response, and what happens when that response becomes maladaptive? The answer lies in the intricate signaling cascade of the hypothalamic-pituitary-adrenal (HPA) axis and its primary effector hormone, cortisol.

Core Principles of the Stress Response

The stress response is a conserved neuroendocrine mechanism that mobilizes energy substrates, suppresses non-essential functions, and heightens vigilance in the face of real or perceived threats. It operates through two primary efferent arms: the rapid sympatho-adrenomedullary (SAM) axis, which releases catecholamines within seconds, and the slower hypothalamic-pituitary-adrenal (HPA) axis, which releases cortisol over minutes to hours. Together, these systems ensure that the organism can respond to acute danger while also sustaining metabolic adaptations during prolonged stress. However, chronic activation of these axes leads to pathological states that healthcare providers encounter routinely in clinical practice.

The HPA Axis — Visual Pathway

As depicted in the diagram, the HPA axis functions as a neuroendocrine amplification cascade. A relatively small quantity of CRH (measured in picograms) stimulates the release of substantially larger quantities of ACTH (nanograms), which in turn drives the secretion of cortisol at microgram-to-milligram levels. This amplification ensures a robust response even to subtle stressors. The negative feedback loop, mediated by cortisol binding to glucocorticoid receptors (GR) in the hippocampus, hypothalamus, and pituitary, serves as a critical brake on the system. Disruption of this feedback—whether through receptor downregulation in chronic stress or exogenous corticosteroid administration—is a fundamental mechanism in many clinical pathologies. Note also the parallel SAM axis, which releases epinephrine and norepinephrine within seconds and mediates the acute cardiovascular and metabolic changes of the fight-or-flight response before cortisol levels have even begun to rise.

Cortisol Synthesis, Transport & Mechanism of Action

Cortisol Biosynthesis

Cortisol is a 21-carbon glucocorticoid synthesized from cholesterol in the zona fasciculata of the adrenal cortex. The biosynthetic pathway involves sequential hydroxylation reactions catalyzed by cytochrome P450 enzymes. Cholesterol is first converted to pregnenolone by CYP11A1 (cholesterol side-chain cleavage enzyme), which is the rate-limiting step regulated by ACTH via cAMP-dependent signaling. Pregnenolone is then converted through intermediates (17α-hydroxypregnenolone, 17α-hydroxyprogesterone, 11-deoxycortisol) to cortisol. ACTH acutely upregulates StAR protein (Steroidogenic Acute Regulatory protein), which transports cholesterol across the mitochondrial membrane, and chronically increases transcription of steroidogenic enzymes.

Transport & Metabolism

In the circulation, approximately 90% of cortisol is bound to corticosteroid-binding globulin (CBG, transcortin) and about 7% is bound to albumin, leaving only roughly 3−5% in the free, biologically active form. The total plasma cortisol concentration at the morning peak is approximately 10−20 µg/dL (275−550 nmol/L), whereas the late-night nadir falls below 5 µg/dL. The half-life of cortisol in the circulation is approximately 60−90 minutes. Cortisol is metabolized primarily in the liver by 5α-reductase and 5β-reductase, then conjugated and excreted in the urine. An important local regulatory mechanism involves the enzyme 11β-hydroxysteroid dehydrogenase (11β-HSD): type 2 converts cortisol to inactive cortisone (protecting mineralocorticoid receptors in the kidney), while type 1 regenerates cortisol from cortisone in metabolically active tissues like liver and adipose.

Intracellular Signaling: GR Activation

Free cortisol diffuses across cell membranes and binds to the cytoplasmic glucocorticoid receptor (GR, NR3C1), which is complexed with heat shock proteins (HSP90, HSP70) in its inactive state. Upon ligand binding, the receptor dissociates from the chaperone complex, dimerizes, and translocates to the nucleus. There it binds glucocorticoid response elements (GREs) in DNA to activate or repress transcription. Transactivation (binding positive GREs) upregulates metabolic enzymes such as phosphoenolpyruvate carboxykinase (PEPCK) for gluconeogenesis. Transrepression (interaction with transcription factors like NF-κB and AP-1) suppresses pro-inflammatory cytokine genes, accounting for cortisol's potent anti-inflammatory and immunosuppressive actions.

Systemic Effects of Cortisol

Cortisol's physiological effects are widespread and touch virtually every organ system. Understanding these effects is critical for healthcare providers because they explain both the utility of endogenous cortisol as an adaptive hormone and the devastating consequences of glucocorticoid excess—whether from Cushing syndrome, chronic stress, or iatrogenic corticosteroid therapy. The following diagram provides an organ-system overview, and the table below details the specific mechanisms involved.

Worked Example: Interpreting HPA Axis Dysfunction

Consider the following clinical scenario, which integrates the physiological principles discussed above. This type of reasoning is essential for healthcare professionals evaluating patients with suspected adrenal pathology.

Cortisol Excess vs. Cortisol Deficiency — Clinical Comparison

A thorough understanding of cortisol physiology requires comparing the clinical manifestations of excess and deficiency, as these represent opposite ends of a single pathophysiological spectrum. Recognizing these patterns is fundamental to the differential diagnosis of adrenal disorders, and the contrasts illuminate why cortisol's effects are dose-dependent and time-dependent.

Connection to Advanced Pathophysiology

The basic HPA axis physiology discussed so far provides a foundation for understanding more complex and clinically nuanced topics that are increasingly relevant in modern healthcare. Three areas of active research and clinical importance deserve attention: the relationship between chronic stress and metabolic syndrome, the concept of allostatic load, and the emerging role of HPA axis epigenetics in intergenerational health outcomes.

These advanced topics illustrate that the stress response is not simply an on/off switch but rather a complex adaptive system whose dysregulation contributes to many of the chronic diseases that dominate modern clinical practice. As healthcare providers, you will encounter the consequences of HPA axis dysfunction in patients with obesity, depression, chronic pain, autoimmune disease, and cardiovascular disease—often overlapping in the same individual. Future coursework in psychiatric pathophysiology, metabolic endocrinology, and clinical pharmacology will build directly on the principles covered here.

Practice Problems

Summary — Stress Response & Cortisol